Filing Flows › aTYR Pharma (ATYR) › Recalls, complaints & regulation
aTYR Pharma (ATYR): clinical trials
aTYR Pharma (ATYR) beyond its filings: 1 active clinical trial.
aTYR Pharma's latest quarter
aTYR Pharma, Q3 2025: revenue $190K, net loss $25.7M, operating cash flow −$20.5M. The chart follows the revenue to costs, profit and cash.
Questions
How many clinical trials does aTYR Pharma have?
1 active study on ClinicalTrials.gov, 0 in phase 3.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.